1. Home
  2. WKC vs RCUS Comparison

WKC vs RCUS Comparison

Compare WKC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WKC
  • RCUS
  • Stock Information
  • Founded
  • WKC 1984
  • RCUS 2015
  • Country
  • WKC United States
  • RCUS United States
  • Employees
  • WKC N/A
  • RCUS N/A
  • Industry
  • WKC Oil Refining/Marketing
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WKC Energy
  • RCUS Health Care
  • Exchange
  • WKC Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • WKC 1.4B
  • RCUS 1.2B
  • IPO Year
  • WKC N/A
  • RCUS 2018
  • Fundamental
  • Price
  • WKC $25.17
  • RCUS $16.91
  • Analyst Decision
  • WKC Hold
  • RCUS Buy
  • Analyst Count
  • WKC 4
  • RCUS 8
  • Target Price
  • WKC $28.75
  • RCUS $26.00
  • AVG Volume (30 Days)
  • WKC 695.7K
  • RCUS 1.1M
  • Earning Date
  • WKC 10-23-2025
  • RCUS 11-05-2025
  • Dividend Yield
  • WKC 3.18%
  • RCUS N/A
  • EPS Growth
  • WKC N/A
  • RCUS N/A
  • EPS
  • WKC N/A
  • RCUS N/A
  • Revenue
  • WKC $38,747,200,000.00
  • RCUS $262,000,000.00
  • Revenue This Year
  • WKC N/A
  • RCUS N/A
  • Revenue Next Year
  • WKC $2.16
  • RCUS N/A
  • P/E Ratio
  • WKC N/A
  • RCUS N/A
  • Revenue Growth
  • WKC N/A
  • RCUS 6.07
  • 52 Week Low
  • WKC $22.71
  • RCUS $6.50
  • 52 Week High
  • WKC $31.64
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • WKC 38.86
  • RCUS 71.13
  • Support Level
  • WKC $24.73
  • RCUS $14.26
  • Resistance Level
  • WKC $25.75
  • RCUS $17.19
  • Average True Range (ATR)
  • WKC 0.51
  • RCUS 1.03
  • MACD
  • WKC -0.09
  • RCUS 0.22
  • Stochastic Oscillator
  • WKC 19.78
  • RCUS 90.08

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: